Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials

Author:

Fernández-González Sara María1ORCID,Moreno-Álvarez Ana1ORCID,Solar-Boga Alfonso1

Affiliation:

1. Pediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Pediatrics, A Coruña University Hospital, Area Sanitaria A Coruña-Cee, 15006 A Coruña, Spain

Abstract

This systematic review was conducted with the objective of understanding the efficacy and safety of proton pump inhibitors (PPIs) in the pediatric population. We used PubMed to identify randomized controlled trials (RCTs) published between 1 June 2010 and 30 June 2023, performed in patients from birth to 18 years old with gastroesophageal reflux disease (GERD) who received treatment with any PPI. This literature search yielded 76 articles and 13 of these met the inclusion criteria. For infants, PPIs were equal to placebos in reducing GERD symptoms in four articles. In one article, the numbers of GER episodes and esophageal acid exposures were lower in infants who received PPIs in the left lateral position, but there was generally no significant improvement in symptoms. In another publication, the combination of PPIs and feeding modifications (FMs) was not more effective than PPIs alone. For children and adolescents, PPIs were effective in improving symptoms and achieving endoscopic healing, which was subsequently maintained. To conclude, PPIs are not effective in reducing the symptoms related to GERD in infants but are effective in older children, where histological remission can be seen. Generally, PPIs are well tolerated, but it is important to remember the possible adverse events (AEs), especially if PPIs are used for an extended period.

Funder

Professor Novoa Santos Foundation

Publisher

MDPI AG

Reference62 articles.

1. Pharmacological treatment of gastro-oesophageal reflux in children;Tighe;Cochrane Database Syst. Rev.,2023

2. Reflujo gastroesofágico y esofagitis en niños;Ramos;Trat en Gastroenterol Hepatol y Nutr pediátrica,2008

3. Gastroesophageal reflux disease in children: What’s new right now?;Sintusek;World J. Gastrointest. Endosc.,2023

4. Prevalence of gastroesophageal reflux disease in children with extraesophageal manifestations using combined-video, multichannel intraluminal impedance-pH study;Eiamkulbutr;World J. Clin. Pediatr.,2023

5. Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children;Singendonk;J. Pediatr. Gastroenterol. Nutr.,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. СУЧАСНИЙ ПОГЛЯД НА РЕФЛЮКСНУ ХВОРОБУ У ДІТЕЙ;Здобутки клінічної і експериментальної медицини;2024-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3